Clinical Trials Logo

Filter by:
NCT ID: NCT04981392 Completed - Covid19 Clinical Trials

Intervention to Promote COVID-19 Vaccination

Start date: June 2, 2022
Phase: N/A
Study type: Interventional

The study aims to implement and assess the impact of a multi-faceted intervention to support Primary Care Provider (PCP) outreach, and PCP and community organization dissemination of information to promote COVID-19 vaccination among vulnerable patients in and near Worcester, MA.

NCT ID: NCT04981275 Completed - Clinical trials for Polycystic Ovary Syndrome

A Multi-omic Approach to Evaluate and Characterize the Polycystic Ovary Syndrome (PCOS) Phenotype

Start date: June 19, 2021
Phase:
Study type: Observational

The purpose of this research study is to explore the relationship between the gut microbiome and hormone levels in women diagnosed with PCOS and determine whether there are differences in the gut microbiome between women with PCOS and women without PCOS. Consented, enrolled participants will complete a health questionnaire, complete a fasted blood draw at a local laboratory, and provide a stool, saliva, and vaginal swab sample for comprehensive biomarkers, hormones, metagenomics, and metabolomics analysis.

NCT ID: NCT04980807 Completed - Clinical trials for Charcot-Marie-Tooth Disease

Observational Study of Neuromuscular Function in CMT Type 1&2 and Healthy Controls

ESTABLISH
Start date: April 7, 2021
Phase:
Study type: Observational

The primary aim of this study is to discover whether patients with CMT type 1 and 2 have neuromuscular junction transmission deficits. The secondary aim is to collect information of different clinical and electrophysiological test procedures to perform possible future clinical trials in CMT patients.

NCT ID: NCT04980573 Completed - Covid19 Clinical Trials

Essential Oils and Post COVID-19 Fatigue

Start date: August 5, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the efficacy of plant based aromas on energy levels among otherwise healthy female survivors of COVID-19.

NCT ID: NCT04980521 Completed - Lung Cancer Clinical Trials

Promoting Radon Testing Via Smartphone App: A Clinical Trial in a High Radon State

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

This research will compare (1) the effectiveness of a mobile radon-education app (vs. traditional brochures) and (2) that of the radon app with in-app reminders (vs. the radon app without in-app reminders and the no app use with postal reminders) to increase radon awareness and testing among North Dakotans. The prevalence of exceptionally high levels of residential radon in ND, coupled with public's poor understanding of this hazard, is a critical public health problem.

NCT ID: NCT04980456 Completed - Myopia Clinical Trials

Clinical Assessment of Two Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lenses

Start date: August 5, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the clinical performance of TOTAL30 contact lenses with Biofinity contact lenses over 30 days of daily wear.

NCT ID: NCT04980378 Completed - Clinical trials for Cervical Degenerative Disc Disorder

Post Approval Study Protocol for the Two Level Simplify® Cervical Artificial Disc

Start date: August 1, 2021
Phase:
Study type: Observational

This study is intended to demonstrate the 5-year long-term safety and efficacy of the Simplify® Cervical Artificial Disc ("Simplify Disc") in subjects enrolled in the non-randomized two-level Simplify Disc Investigational Device Exemption (IDE) study. This study was conducted under IDE G150206

NCT ID: NCT04980365 Completed - Clinical trials for Stress, Psychological

Psychology Mobile Apps for Parents in a Pandemic

Start date: June 8, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether parents of young children (aged 10 and under) think it is feasible (in other words, doable) and acceptable (in other words, satisfactory) to use a mobile app designed to provide personalized education and enrichment for 10 minutes/day for 14 days. The investigators hope to learn if it is reasonable to ask parents to use one of three different apps and if parents are satisfied with their participation in the study. If so, the investigators can continue to study the effect of these apps on parents' stress in future research. The investigators also plan to evaluate the effect of these app-based interventions in lowering levels of stress in parents during the COVID-19 pandemic. By conducting this study, the investigators hope to learn if there are specific app-based interventions that will lead to a reduction in stress in parents, improved parental life satisfaction, and improved parent-child interactions. If the results of this study suggest these apps may be promising at reducing stress among parents, the investigators will continue doing research on these app-based interventions.

NCT ID: NCT04980300 Completed - Knee Osteoarthritis Clinical Trials

Delaware Physical Exercise and Activity for Knee Osteoarthritis

PEAK
Start date: July 3, 2021
Phase: N/A
Study type: Interventional

The objective of this project is to examine the efficacy of an innovative Telehealth Physical Therapy (PT) program for adults with knee osteoarthritis (OA) to increase physical activity over 12 weeks in adults with knee OA compared to a control group receiving web-based resources about knee OA. One hundred individuals with knee osteoarthritis (OA), who are over the age of 45, and are also looking to move more, will be randomized into a brief or expanded intervention group. The brief intervention includes an online, guided video orientation from a physical therapist to web resources for strengthening exercises, physical activity, and pain management strategies for knee OA. The expanded program includes up to 5 online consultations with a physical therapist over a 12-week period who will prescribe strengthening exercises, physical activity goals, and pain management strategies for knee OA.

NCT ID: NCT04980248 Completed - Hypophosphatasia Clinical Trials

Study of ALXN1850 in Participants With Hypophosphatasia (HPP)

Start date: August 16, 2021
Phase: Phase 1
Study type: Interventional

This is an open-label, dose-escalating study to assess safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD), and immunogenicity of ALXN1850 when given intravenous (IV) and subcutaneous (SC) to adults with HPP.